Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rochelle Castillo, M.D.

Concepts (144)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Psoriatic820242192.280 Why?
Psoriasis920249442.010 Why?
Dermatomyositis520242581.910 Why?
Alopecia Areata120221280.670 Why?
Finger Phalanges12019410.650 Why?
Ecosystem120234870.640 Why?
Awards and Prizes120223600.580 Why?
Brain Abscess120171200.530 Why?
Rheumatology120226150.510 Why?
Dermatitis, Atopic120217310.450 Why?
Gingival Diseases12014360.450 Why?
Lymphohistiocytosis, Hemophagocytic120172690.430 Why?
Facial Dermatoses12014860.430 Why?
Pemphigoid, Bullous120141120.390 Why?
Dermatology120229180.390 Why?
Radiography1201969610.300 Why?
Bone Neoplasms1201925270.280 Why?
Ultrasonography1201959640.260 Why?
Carcinoma, Squamous Cell1201940200.220 Why?
Raynaud Disease12023790.210 Why?
Connective Tissue Diseases120242850.190 Why?
Antirheumatic Agents2202113650.190 Why?
Dermatologic Agents220243130.180 Why?
Autoimmune Diseases3202422380.180 Why?
Epithelium2202416030.180 Why?
Duodenal Diseases12021990.180 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120246190.180 Why?
Glycolysis120248350.170 Why?
Enteritis120211620.170 Why?
Thrombotic Microangiopathies120211230.160 Why?
Uremia120192020.160 Why?
Interferons120227030.150 Why?
Anti-Bacterial Agents1201774020.150 Why?
Lupus Erythematosus, Systemic2202121520.150 Why?
Interleukin-17120249110.150 Why?
Alopecia120224120.150 Why?
Methotrexate1202417160.140 Why?
Skin4202444730.140 Why?
Arthritis120226800.140 Why?
Biological Products320219120.140 Why?
Immunoglobulins, Intravenous120216640.140 Why?
Topoisomerase II Inhibitors12017940.140 Why?
Microvessels120215770.130 Why?
Pruritus120193780.130 Why?
Pyrroles1202211250.130 Why?
Etoposide120176340.130 Why?
Lung Diseases, Interstitial120249180.120 Why?
Lung Neoplasms12019133820.120 Why?
Neutrophil Infiltration120173900.120 Why?
Immunotherapy, Adoptive1202414670.120 Why?
Humans2620247606170.120 Why?
Cheek12014650.110 Why?
Diagnosis, Differential32021129660.110 Why?
Piperidines1202216550.110 Why?
Blindness120175840.110 Why?
Molecular Targeted Therapy1202428120.100 Why?
Giant Cell Arteritis120173060.100 Why?
Craniotomy120177410.100 Why?
Infusions, Intravenous1201722140.100 Why?
Immunosuppressive Agents1202441740.090 Why?
Drug Therapy, Combination2202163050.090 Why?
Drug Monitoring120179600.090 Why?
Adult1220242209690.090 Why?
Renal Dialysis1201917990.090 Why?
Nose120145210.090 Why?
Pyrimidines1202230270.090 Why?
Intestinal Mucosa1202130310.080 Why?
Dexamethasone1201719470.080 Why?
Prednisone1201415620.080 Why?
Arthritis, Rheumatoid2202037520.080 Why?
Inflammation32024107600.070 Why?
HIV Infections12014173370.070 Why?
Anti-Inflammatory Agents1201718100.070 Why?
Kidney Failure, Chronic1201924770.070 Why?
Proteomics1202038360.070 Why?
Carcinoma, Renal Cell1202131640.070 Why?
Administration, Oral1201440100.060 Why?
Treatment Outcome52022645680.060 Why?
Combined Modality Therapy1201785160.060 Why?
Kidney Neoplasms1202142500.060 Why?
Neoplasm Staging12019111160.060 Why?
Genomics1202058220.060 Why?
Cell Differentiation12021115140.060 Why?
Glucose Transporter Type 1120241860.060 Why?
Male1020243603580.050 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3120241520.050 Why?
Disease Progression12020134950.050 Why?
Coronavirus Infections1202030880.050 Why?
Pneumonia, Viral1202032090.050 Why?
Female1120243921480.050 Why?
Biopsy1201467620.050 Why?
Administration, Cutaneous120247120.050 Why?
Middle Aged820242205840.050 Why?
Complement Pathway, Mannose-Binding Lectin12021280.050 Why?
Interleukin-23120222010.050 Why?
Genome-Wide Association Study12020126610.050 Why?
Antineoplastic Combined Chemotherapy Protocols12021117360.040 Why?
National Institutes of Health (U.S.)120237940.040 Why?
Severity of Illness Index32022158280.040 Why?
Lactic Acid1202411390.040 Why?
Fibrin Fibrinogen Degradation Products120214260.040 Why?
Spondylitis, Ankylosing120201550.040 Why?
Endoscopy, Digestive System120213520.040 Why?
Complement System Proteins120217340.040 Why?
New York120208740.040 Why?
Multicenter Studies as Topic1202217000.040 Why?
Th17 Cells120247930.040 Why?
Urea120194430.040 Why?
Dizziness120192590.030 Why?
Edema120217650.030 Why?
Necrosis1202116100.030 Why?
Immunomodulation120205480.030 Why?
Risk Factors32024741150.030 Why?
Remission Induction1202123910.030 Why?
Randomized Controlled Trials as Topic22022101990.030 Why?
Autoantibodies1202221150.030 Why?
Incidence22022213370.030 Why?
Ischemia1202118840.020 Why?
Aged520241690420.020 Why?
Glucocorticoids1202021600.020 Why?
Vaccination1202233700.020 Why?
Magnetic Resonance Imaging12017364020.020 Why?
Chronic Disease1202493110.020 Why?
Mice, Knockout12024143890.020 Why?
Double-Blind Method12022123340.020 Why?
RNA, Messenger12022127580.020 Why?
Immunohistochemistry12021110690.020 Why?
Reproducibility of Results12024200740.020 Why?
Prospective Studies22020543600.020 Why?
Case-Control Studies12023221480.020 Why?
Mice, Inbred C57BL12024221150.020 Why?
Inflammatory Bowel Diseases1202024230.020 Why?
Disease Models, Animal12024182210.010 Why?
United States22023722720.010 Why?
Depression1202381320.010 Why?
Cohort Studies12024414570.010 Why?
Signal Transduction12024234160.010 Why?
Hospitalization12020107040.010 Why?
Pandemics1202086450.010 Why?
Tomography, X-Ray Computed12021205560.010 Why?
Mice12024813680.010 Why?
Aged, 80 and over12020588940.010 Why?
Young Adult12020591790.010 Why?
Animals120241682010.010 Why?
Castillo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (144)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.